Table 13Raised risk (6% 10-year risk for a 40-year old)

Screening methodTotal cost (£million)Cost relative to no screening (£M)Total QALY’sQALY’s relative to no screening
No screening0.907018 0990
Mammography2.1311.22418 16970
MRI3.8972.99018 200101
Combined4.3163.40918 210111

From: 5, Cost-Utility Analysis

Cover of Familial Breast Cancer
Familial Breast Cancer: The Classification and Care of Women at Risk of Familial Breast Cancer in Primary, Secondary and Tertiary Care: Update [Internet].
NICE Clinical Guidelines, No. 41.
National Collaborating Centre for Primary Care (UK).
Copyright © 2006, National Collaborating Centre for Primary Care.

PubMed Health. A service of the National Library of Medicine, National Institutes of Health.